Dexamethasone inhibits proliferation and stimulates ecto-5′-nucleotidase/CD73 activity in C6 rat glioma cell line

Journal of Neuro-Oncology

Volumn 84, Issue 1, 2007, Pages 1-8

  Bavaresco, Luci ^a   Bernardi, Andressa ^a   Braganhol, Elizandra ^a   Wink, Márcia R ^b   Battastini, Ana Maria Oliveira ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Adenosine; C6 glioma cells; Dexamethasone; Ecto 5 nucleotidase CD73

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 5' NUCLEOTIDASE; ADENOSINE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; DEXAMETHASONE; ECTO 5' NUCLEOTIDASE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; PROTEIN KINASE C INHIBITOR; PURINE;

ANIMAL CELL; ARTICLE; CATABOLISM; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; GLIOMA CELL; HYDROLYSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; TUMOR CELL LINE;

5'-NUCLEOTIDASE; ADENOSINE MONOPHOSPHATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; PROTEIN KINASE C; PURINES; RATS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 34547136486     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9342-2     Document Type: Article

References (33)

1. Weller M, Schmidt C, Roth W, Dichgans J (1997) Chemotherapy of human malignant glioma: Prevention of efficacy by dexamethasone? Neurology 48:1704-1709
2. Naumann U, Durka S, Weller M (1998) Dexamethasone-mediated protection from drug cytotoxicity: Association with p21WAF1/CIP1 protein accumulation? Oncogene 17:1567-1575
3. Wolff JE, Jurgens H (1994) Dexamethasone induced partial resistance to methotrexate in C6-glioma cells. Anticancer Res 14:1585-1588
4. Wolff JE, Denecke J, Jurgens H (1996) Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. Anticancer Res 16:805-809
5. Cui X, Thomas A, Han Y, Palamanda J, Montgomery D, White RE, Lorrison RA, Cheng KC (2005) Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: Correlation study with induction in vivo. J Pharmacol Toxicol Methods 52(2):234-243
6. Baldwin SJ, Bramhall JL, Ashby CA, Yue L, Murdock PR, Hood SR, Ayrton AD, Clarke SE (2006) Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan). Drug Metab Dispos 34(6):1063-1069
7. Kaup B, Schindler I, Knupfer H, Schlenzka A, Preiss R, Knupfer MM (2001) Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J Neurooncol 51:105-110
8. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
9. Burnstock G (2006) Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27:166-176
10. White N, Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27(4):211-217
11. Zimmermann H (2001) Ectonucleotidases: Some developments and a note on nomenclature. Drug Dev Res 52:44-56
12. Zimmermann H (1992) 5′-Nucleotidase: Molecular structure and functional aspects. Biochem J 285(Pt 2):345-365
13. Robson SC, Sévigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: Structure functions relationships and pathophysiological significance. Purinergic Signal 2:409-430
14. Jacobson KA, Hoffmann C, Cattabeni F, Abbracchio MP (1999) Adenosine-induced cell death: Evidence for receptor-mediated signalling. Apoptosis 4:197-211
15. Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG, Tabrizi MA, Borea PA (2003) A glance at adenosine receptors: Novel target for antitumor therapy. Pharmacol Ther 100:31-48
16. Benda P, Lightbody J, Sato G, Levine L, Sweet W (1968) Differentiated rat glial cell strain in tissue culture. Science 161:370-371
17. Grobben B, De Deyn PP, Slegers H (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257-270
18. Jungmann RA, Wang XS, Milkowski DM, Short ML (1992) Glucocorticoid induction of CRE-binding protein isoform mRNAs in rat C6 glioma cells. Nucleic Acids Res 20:825-829
19. Wink MR, Lenz G, Braganhol E, Tamajusuku ASK, Schwartsmann G, Sarkis JJ, Battastini AMO (2003) Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 198:211-218
20. Morrone FB, Oliveira DL, Gamermann P, Stella J, Wofchuk S, Wink MR, Meurer L, Edelweiss MI, Lenz G, Battastini AM (2006) In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 6:226
21. Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+ -stimulated ATPase activity. Anal Biochem 157:375-380
22. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
23. Barreto-Chaves ML, Aneas I, Krieger JE (2001) Glucocorticoid regulation of angiotensin-converting enzyme in primary culture of adult cardiac fibroblasts. Am J Physiol Regul Integr Comp Physiol 280:R25-R32
24. Gorman AM, Hirt UA, Orrenius S, Ceccatelli S (2000) Dexamethasone pre-treatment interferes with apoptotic death in glioma cells. Neuroscience 96:417-425
25. Zhu XY, Liu YJ, Lu J, Xu RB (2004) Knockdown of glucocorticoid receptor expression by RNA interference promotes cell proliferation in murine macrophage RAW264.7 cells. J Steroid Biochem Mol Biol 92:375-382
26. Makino A, Ozaki Y, Matsubara H, Sato T, Ikuta K, Nishizawa Y, Suzumori K (2005) Role of apoptosis controlled by cytochrome c released from mitochondria for luteal function in human granulosa cells. Am J Reprod Immunol 53:144-152
27. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608-1621
28. Yamamoto S, Jiang H, Nishikawa K, Ishihara M, Wang JC, Kato R (1992) Protein kinase C-dependent and -independent actions of a potent protein kinase C inhibitor, staurosporine. Eur J Pharmacol 227:113-122
29. Maddali KK, Korzick DH, Turk JR, Bowles DK (2005) Isoform-specific modulation of coronary artery PKC by glucocorticoids. Vascul Pharmacol 42:153-162
30. Node K, Kitakaze M, Minamino T, Tada M, Inoue M, Hori M, Kamada T (1997) Activation of ecto-5′-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart. Br J Pharmacol 120:273-281
31. Sadej R, Spychala J, Skladanowski AC (2006) Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res 16:213-222
32. Ohana G, Bar-Yehuda S, Barer F, Fishman P (2001) Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor. J Cell Physiol 186:19-23
33. Gomez G, Sitkovsky MV (2003) Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102:4472-4478